GlassScriptPhysician profile
Stacy C Butler
NPI 1225246622
$7,604.07
in general payments reported to CMS, 2019-2025
23 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $444 · 2021: $662 · 2022: $226 · 2023: $5,554 · 2024: $195 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $5,051 · Food and Beverage: $746 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $5,050.82 |
| Food and Beverage | $745.85 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $5,050.82 | 2023 | |
| Abbvie INC. | $605.40 | 2019-2023 | Lo Loestrin Fe |
| Coopersurgical, INC. | $291.73 | 2019-2022 | |
| Exeltis, USA INC. | $259.73 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $232.39 | 2023 | Veozah |
| Organon LLC | $187.52 | 2021-2024 | Nexplanon, Nuvaring |
| Hologic Sales and Service, LLC | $183.64 | 2021-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $153.31 | 2021-2023 | |
| Therapeuticsmd, INC. | $147.55 | 2019-2021 | |
| Agile Therapeutics, INC. | $99.25 | 2021-2023 | Twirla |
| Evofem Biosciences, INC. | $48.50 | 2021 | |
| Roche Diagnostics Corporation | $47.05 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $44.16 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $41.69 | 2019-2022 | |
| Myovant Sciences INC. | $30.60 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $29.58 | 2021-2024 | |
| Avion Pharmaceuticals | $27.73 | 2019 | |
| Ethicon US, LLC | $27.35 | 2025 | Vistaseal |
| Merck Sharp & Dohme LLC | $25.65 | 2020-2021 | |
| Biogen, INC. | $24.28 | 2025 | Zurzuvae |
| Meditrina | $19.25 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.07 | 2019 | |
| Ascend Therapeutics US, LLC | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.